These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32781928)

  • 1. COVID-19 Could Change the Way We Respond to the Opioid Crisis-for the Better.
    Bao Y; Williams AR; Schackman BR
    Psychiatr Serv; 2020 Dec; 71(12):1214-1215. PubMed ID: 32781928
    [No Abstract]   [Full Text] [Related]  

  • 2. The opioid crisis: Origins, trends, policies, and the roles of pharmacists.
    Chisholm-Burns MA; Spivey CA; Sherwin E; Wheeler J; Hohmeier K
    Am J Health Syst Pharm; 2019 Mar; 76(7):424-435. PubMed ID: 31361827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada.
    Strike C; Watson TM
    Int J Drug Policy; 2019 Sep; 71():178-182. PubMed ID: 30975595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid use disorder and COVID-19: Implications for policy and practice.
    Mitchell M; Shee K; Champlin K; Essary AC; Evans M
    JAAPA; 2021 Jun; 34(6):1-4. PubMed ID: 34031321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The escalation of the opioid epidemic due to COVID-19 and resulting lessons about treatment alternatives.
    Silva MJ; Kelly Z
    Am J Manag Care; 2020 Jul; 26(7):e202-e204. PubMed ID: 32672917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the COVID-19 pandemic on opioid overdose and other adverse events in the USA and Canada: a systematic review.
    Simha S; Ahmed Y; Brummett CM; Waljee JF; Englesbe MJ; Bicket MC
    Reg Anesth Pain Med; 2023 Jan; 48(1):37-43. PubMed ID: 36202619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Opioid Epidemic and Psychiatry: The Time for Action Is Now.
    Brunette MF; Oslin DW; Dixon LB; Adler DA; Berlant J; Erlich M; First MB; Goldman B; Levine B; Siris S; Winston H
    Psychiatr Serv; 2019 Dec; 70(12):1168-1171. PubMed ID: 31500545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing co-occurring public health emergencies: The importance of naloxone distribution in the era of COVID-19.
    Collins AB; Ndoye CD; Arene-Morley D; Marshall BDL
    Int J Drug Policy; 2020 Sep; 83():102872. PubMed ID: 32713765
    [No Abstract]   [Full Text] [Related]  

  • 9. Medication-assisted therapies--tackling the opioid-overdose epidemic.
    Volkow ND; Frieden TR; Hyde PS; Cha SS
    N Engl J Med; 2014 May; 370(22):2063-6. PubMed ID: 24758595
    [No Abstract]   [Full Text] [Related]  

  • 10. The Hidden Epidemic of Opioid Overdoses During the Coronavirus Disease 2019 Pandemic.
    Kosten TR; Petrakis IL
    JAMA Psychiatry; 2021 Jun; 78(6):585-586. PubMed ID: 33377967
    [No Abstract]   [Full Text] [Related]  

  • 11. Opioid Use Disorder and COVID-19: Crashing of the Crises.
    Khatri UG; Perrone J
    J Addict Med; 2020; 14(4):e6-e7. PubMed ID: 32404651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing Medication Treatment of Opioid Use Disorder During COVID-19 (SARS-CoV-2).
    Leppla IE; Gross MS
    J Addict Med; 2020; 14(4):e1-e3. PubMed ID: 32412931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tripping point: The potential role of psychedelic-assisted therapy in the response to the opioid crisis.
    Argento E; Tupper KW; Socias ME
    Int J Drug Policy; 2019 Apr; 66():80-81. PubMed ID: 30743091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Emergency Medical Services in the Opioid Epidemic.
    Joiner A; Kumar L; Barhorst B; Braithwaite S;
    Prehosp Emerg Care; 2021; 25(4):462-464. PubMed ID: 32795103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an Unsanctioned Safe Consumption Site in the United States.
    Kral AH; Lambdin BH; Wenger LD; Davidson PJ
    N Engl J Med; 2020 Aug; 383(6):589-590. PubMed ID: 32640126
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review.
    Alexander K; Pogorzelska-Maziarz M; Gerolamo A; Hassen N; Kelly EL; Rising KL
    Subst Abuse Treat Prev Policy; 2021 Aug; 16(1):60. PubMed ID: 34372900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the impact of naloxone dispensation at public health vending machines in Clark County, Nevada.
    Allen ST; O'Rourke A; Johnson JA; Cheatom C; Zhang Y; Delise B; Watkins K; Reich K; Reich R; Lockett C
    Ann Med; 2022 Dec; 54(1):2692-2700. PubMed ID: 36168975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update: COVID-19 Upends Progress on Opioid Crisis.
    Am J Nurs; 2020 Oct; 120(10):16. PubMed ID: 32976135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harm reduction and the opioid crisis: Emerging policy challenges.
    Greer A; Ritter A
    Int J Drug Policy; 2019 Sep; 71():139-141. PubMed ID: 31160155
    [No Abstract]   [Full Text] [Related]  

  • 20. OVERDOSED ON OPIOIDS: A deadly opioid epidemic sweeping the country has lawmakers working hard to find solutions.
    Hoback J
    State Legis; 2016 Apr; 42(4):9-13. PubMed ID: 27071212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.